SAN DIEGO, June 24, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced that 14 additional hospitals across the country have adopted the ...

To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/53365-carefusion-unveils-pyxis-automated-medication-dispensing ...

CareFusion, a medical technology company, has announced it has acquired Vestara, a California-based company focused on developing solutions for the management of pharmaceutical waste. The company said ...

SAN DIEGO, Dec. 7 CareFusion (NYSE: CFN), a leading, global medical device company, today announced six new Pyxis® medication management products at the 44th American Society for Health System ...

KSA, 12 May 2013 CareFusion, a leading global medical technology company, announced it will highlight its medication safety solutions at Saudi Health, being held at the Riyadh International Convention ...

When patients begin receiving care at St. Luke's Same Day Surgery Center in April, they'll receive medications through a computerized pharmacy system that's been in use throughout St. Luke's Regional ...

San Diego-based CareFusion has been putting fingerprint scanners in its medication cabinets since 1999 and in 2001 the company made it a standard in all its Pyxis medication dispensing units. But over ...

CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology (“Pyxis” or the "Company”) today announced that it has entered into a worldwide license agreement with Pfizer Inc. (NYSE:PFE) for ...

Pyxis Oncology is aiming to close out a transformative 2021 with an IPO. Having licensed a pair of antibody-drug conjugates (ADCs) from Pfizer and raised a megaround to develop them, Pyxis is now ...

Pyxis Oncology has plenty to do with three antibody-drug conjugates in the pipeline, so the upstart biotech has formed a new joint venture called Kyma Therapeutics with Alloy Therapeutics to develop ...

Stephens has initiated coverage on Pyxis Oncology Inc (NASDAQ:PYXS), highlighting the company’s technology platform aimed at developing next-gen antibody-drug conjugates (ADCs) with enhanced potency, ...